Grown Rogue International (GRUSF) EBIT (QoQ) (2009 - 2026)
Grown Rogue International (GRUSF) EBIT (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 739.55% |
| Mar 31, 2026 | -100.00% |
| Dec 31, 2025 | 291.68% |
| Sep 30, 2025 | 100.00% |
| Jun 30, 2025 | -123,046,344,732,991.72% |
| Mar 31, 2025 | -1,282.73% |
| Dec 31, 2024 | -91.62% |
| Sep 30, 2024 | 667.63% |
| Jun 30, 2024 | -89.94% |
| Mar 31, 2024 | 117.55% |
| Oct 31, 2023 | 81.40% |
| Jul 31, 2023 | 9.76% |
| Apr 30, 2023 | 27.83% |
| Jan 31, 2022 | -67.89% |
| Oct 31, 2021 | 111.78% |
| Jul 31, 2021 | 214.86% |
| Apr 30, 2021 | -163.11% |
| Jan 31, 2021 | 1,061.91% |
| Oct 31, 2020 | 85.26% |
| Jul 31, 2020 | -16.48% |